Shanxi Jinbo Bio-pharmaceutical Plans Fundraise with Private Placement and IPO Proceeds
China-based Shanxi Jinbo Bio-pharmaceutical Co., Ltd. (832982.BSE) is poised to raise RMB 36.75 million through...
Finance
Saints Sages Surgical Secures Series B Funding to Advance Energy-Based Devices
Shanghai-based Saints Sages Surgical Co., Ltd, a leading developer of high-value minimally invasive surgical products,...
Eyebright Medical Technology Plans GRD Listing on SIX Exchange to Raise RMB 1.4 Billion
Eyebright Medical Technology Co., Ltd (SHA: 688050), a Beijing-based company specializing in ophthalmic medical devices,...
Suzhou Leadsynbio Secures Series D Funding to Boost R&D and Market Presence
Suzhou Leadsynbio Technology Co., Ltd, a specialist in synthetic biology, has reported raised hundreds of...
Cascade Pharmaceuticals Secures RMB140 Million in Financing to Advance FXR Agonist Clinical Trials
Shanghai-based sino-foreign joint venture, Cascade Pharmaceuticals, Inc., has reportedly raised RMB140 million in a recent...
Novo Nordisk’s H1 2023 Financials Show 30% YOY Growth Driven by GLP-1 Drugs and Obesity Sales
Denmark-based pharmaceutical company Novo Nordisk A/S (NYSE: NVO) has announced its financial results for the...
Beijing’s Gene Cradle Secures Pre-Series B+ Funding Led by Cash Capital
Gene Cradle, a Beijing-based gene therapy specialist, has reportedly secured tens of millions of renminbi...
Gracell Biotechnologies Secures $100 Million in Private Placement with Healthcare Investors
Suzhou-based biotech firm Gracell Biotechnologies Inc., (NASDAQ: GRCL) has announced a purchase agreement with a...
Jumpcan Pharmaceutical Partners with Nanjing Zenshine for Exclusive Promotion Rights of ZX-7101A in China
China-based Jumpcan Pharmaceutical (SHA: 600566) has announced a strategic partnership with fellow Chinese firm Nanjing...
Kunshan Yiyuan Medical Technology Secures Over RMB 100 Million in Series B Financing
Kunshan Yiyuan Medical Technology Co., Ltd (Medical Source), a company in China that specializes in...
ICE Bioscience Secures Series B+ Financing to Boost Integration Capabilities
Beijing-based Contract Research Organization (CRO) ICE Bioscience has reportedly raised close to RMB 100 million...
GeneMind Biosciences Secures RMB 400 Million in Series C Financing to Expand Gene Testing
Shenzhen-based DNA sequencer specialist, GeneMind Biosciences Co., Ltd, has reportedly raised RMB 400 million in...
GluBio Pharmaceutical Secures $22 Million in A+ Round Financing to Advance Protein Degradation Drugs
GluBio Pharmaceutical Co., Ltd., an emerging player in targeted protein degradation drug development, has announced...
Mindray Bio-Medical Electronics to Acquire Majority Stake in DiaSys Diagnostic Systems
Shenzhen Mindray Bio-Medical Electronics Co., Ltd (SHE: 300760), a leading medical device company based in...
EnChannel Secures RMB 200 Million in Series A Funding to Advance Electrophysiology Solutions
EnChannel Medical, a Guangzhou-based electrophysiology platform company, has reportedly secured RMB 200 million (USD 28...
Sinovation Secures Over RMB 100 Million in Series D+ Financing for Neurosurgery Innovations
Beijing-based Sinovation (Beijing) Medical Technology Co., Ltd., a leader in neurosurgery diagnosis, minimally invasive procedure...
Mirxes Holding Company Secures USD 50 Million in Series D Financing for RNA Technology
Mirxes Holding Company Ltd, a Singapore-headquartered RNA technology company specializing in blood-based miRNA test kit...
Kanova Biopharma Secures Over RMB 100 Million in Financing for Autoimmune and Oncology Pipeline
Kanova Biopharma, a Suzhou-based developer of antibodies focused on autoimmune diseases and oncology, has reportedly...
Carbon Medical Technology Secures Over RMB 100 Million in Series A Financing for Interventional Therapy
Shenzhen-based Carbon Medical Technology Co., Ltd has reportedly raised over RMB 100 million (USD 13.9...
Zennova Pharmaceutical Group Secures RMB 100 Million in Series B Financing for Commercial Manufacturing and R&D
China-based Zennova Pharmaceutical Group has reportedly raised close to RMB 100 million (USD 13.9 million)...